Market Research Logo

In Vitro Diagnostics: Technologies and Global Markets

In Vitro Diagnostics: Technologies and Global Markets

The global market for in vitro diagnostics (IVD) products was totaled at $57.3 billion in 2014. It is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

This report provides:
An overview of the global markets and related technologies for in vitro diagnostics
Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD
Information about IVD products including reagents, instruments, and data management softwares and services
A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories
Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics
Geographical breakdowns
Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others.
Profiles of major players in the industry


SCOPE OF REPORT

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study are diagnostic testing such as imaging, veterinary diagnostics and their associated products.

This study will provide information on these areas:
Structure and current market size of the IVD market as outlined with forecasts through 2020.
Impact of chronic diseases, growing and aging populations.
Current technology and product suppliers and key innovations.
A look at the IVD industry and trends affecting the market.
Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia and LAAM regions.
Emerging opportunities and potential investment opportunity areas for IVD.
Technology patent trends relating to IVD.
Profiles for more than 20 companies in the industry with significant contributions and market shares.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTION OF THE STUDY AND FOR WHOM
SCOPE OF REPORT
METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
INTRODUCTION
GLOBAL MARKET TRENDS
SUMMARY TABLE GLOBAL IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL IVD MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 3 MARKET LANDSCAPE
MARKET OVERVIEW AND SEGMENTATION
FIGURE 1 MARKET SEGMENTATION
KEY FINDINGS
FACTORS INFLUENCING THE GLOBAL IVD MARKET
DRIVERS
Need for Disease Detection before Appearance of Symptoms
Need to Identify the Right Patients for Drug Therapy
Need for Faster Real-Time Tests that Enable Personalized Treatment
Point-of-Care Tests that Minimize Dependency on Lab Testing
Improving Healthcare Budgets Drive Demand for IVD in Emerging
Markets
Rising Aging Population and Global Incidence of Chronic Diseases
Discovery of New Biomarkers and Advances in Molecular Techniques
Public and Environmental Health Monitoring Requires the Use of IVDs for
Faster Diagnosis and Treatment
RESTRAINTS
Declining Reimbursement for IVDs in Europe Reduces Growth
U.S. Medical Device Tax Reduces Profits for Manufacturers
Stringent Regulatory Framework to Stifle the Growth of IVD Market
High R&D and Marketing Costs
Regulatory Disparities and the Expansion of Laboratory-developed Tests
REGULATORY LANDSCAPE
IVD REGULATIONS IN NORTH AMERICA
U.S.
TABLE 1 TYPES OF DIAGNOSTIC TESTS AND HOW THEY ARE
REGULATED
Canada
IVD REGULATIONS IN EUROPE
IVD REGULATIONS IN ASIA
Japan
China
India
Australia and New Zealand
Malaysia
Singapore
TABLE 2 CHANGES IN IVD REGULATIONS IN ASIA
IVD REGULATIONS IN LAAM
Brazil
Mexico
Israel
Saudi Arabia
South Africa
CHAPTER 4 GLOBAL IVD MARKET BY SUBCATEGORIES
INTRODUCTION
DESCRIPTION
IMMUNOCHEMISTRY
POC TESTING
MOLECULAR DIAGNOSTICS
HEMATOLOGY
CLINICAL MICROBIOLOGY
TISSUE DIAGNOSTICS
TRENDS IN IVD SEGMENTS
TABLE 3 GLOBAL IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
FIGURE 2 GLOBAL IVD MARKET BY SEGMENT, 2013-2020 ($ MILLIONS)
FIGURE 3 GLOBAL IVD MARKET SHARE BY SEGMENT, 2014 (%)
COMPETITIVE STRUCTURE
MARKET SHARE ANALYSIS
TABLE 4 MAJOR IVD MARKET COMPANIES, 2014 ($ MILLIONS)
FIGURE 4 MARKET SHARE OF MAJOR IVD MARKET COMPANIES, 2014 (%)
CHAPTER 5 GLOBAL IMMUNOCHEMISTRY MARKET
APPLICATIONS
BLOOD GAS, ELECTROLYTES AND METABOLITES (BGEM)
ENDOCRINE
INFECTIOUS DISEASES
CANCER
URINALYSIS
DIABETES
CARDIOLOGY
BLOOD SCREENING
OTHERS
TABLE 5 GLOBAL IMMUNOCHEMISTRY MARKET BY APPLICATION THROUGH 2020 ($ MILLIONS)
FIGURE 5 GLOBAL IMMUNOCHEMISTRY MARKET SHARE BY APPLICATION, 2014 (%)
TABLE 6 GLOBAL IMMUNOCHEMISTRY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 6 GLOBAL IMMUNOCHEMISTRY MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 6 GLOBAL POC TESTING MARKET
APPLICATIONS
GLUCOSE TESTING
BGEM
CARDIAC MARKER TESTING
INFECTIOUS DISEASE TESTING
PREGNANCY AND FERTILITY TESTING
DRUG AND ALCOHOL ABUSE TESTING
HEMATOLOGY AND HEMOSTASIS TESTING
CHOLESTEROL TESTING
URINE CHEMISTRY TESTING
TUMOR MARKER TESTING
OTHER POC TESTING
TABLE 7 GLOBAL POC TESTING MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
FIGURE 7 GLOBAL POC TESTING MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
FIGURE 8 GLOBAL POC TESTING MARKET SHARE BY APPLICATION, 2014 (%)
TABLE 8 GLOBAL POC TESTING MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 9 GLOBAL POC TESTING MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 7 GLOBAL HEMATOLOGY MARKET
APPLICATIONS
ROUTINE HEMATOLOGY TESTS
HEMOSTASIS
TABLE 9 GLOBAL HEMATOLOGY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
FIGURE 10 GLOBAL HEMATOLOGY MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
FIGURE 11 GLOBAL HEMATOLOGY MARKET SHARE BY APPLICATION, 2014 (%)
FIGURE 12 GLOBAL HEMATOLOGY MARKET SHARE BY TECHNIQUE, 2014 (%)
FIGURE 13 GLOBAL HEMATOLOGY MARKET SHARE BY TECHNIQUE, 2014 (%)
TABLE 10 GLOBAL HEMATOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 14 GLOBAL HEMATOLOGY MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 8 GLOBAL MOLECULAR DIAGNOSTICS MARKET
APPLICATIONS
INFECTIOUS DISEASES
BLOOD SCREENING
ONCOLOGY
GENETIC TESTING
OTHERS (COMPANION DIAGNOSTICS, PRENATAL GENETIC TESTS AND RARE DISEASES)
TABLE 11 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION THROUGH 2020 ($MILLIONS)
FIGURE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
FIGURE 16 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATION, 2014 (%)
FIGURE 17 GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET SHARE BY DISEASE, 2014 (%)
FIGURE 18 COMPANION DIAGNOSTIC TESTS BY YEAR APPROVED, 1994-2014 (NO. OF TESTS)
TABLE 12 COMPANION DIAGNOSTIC TESTS MANUFACTURERS BY NUMBER OF TESTS, 2013
TABLE 13 FDA-APPROVED NUCLEIC ACID BASED TESTS FOR GENETIC
CONDITIONS
TABLE 14 FDA-APPROVED COMPANION DIAGNOSTIC TESTS
TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 9 GLOBAL CLINICAL MICROBIOLOGY MARKET
APPLICATIONS
BLOOD CULTURE
GENERAL CULTURE (URINE/SALIVA/STOOL/SPUTUM/CSF AND OTHER BODY FLUIDS)
IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TESTING
TABLE 16 GLOBAL CLINICAL MICROBIOLOGY MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
FIGURE 20 GLOBAL CLINICAL MICROBIOLOGY MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
FIGURE 21 GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE BY APPLICATION, 2014 (%)
TABLE 17 GLOBAL CLINICAL MICROBIOLOGY MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 22 GLOBAL CLINICAL MICROBIOLOGY MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 10 GLOBAL TISSUE DIAGNOSTICS MARKET
APPLICATIONS
CANCER DIAGNOSIS
TISSUE TYPING
PATHOGEN DETECTION
TABLE 18 GLOBAL TISSUE DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
FIGURE 23 GLOBAL TISSUE DIAGNOSTICS MARKET BY APPLICATION, 2013-2020 ($ MILLIONS)
FIGURE 24 GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY APPLICATION, 2014 (%)
TABLE 19 GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 25 GLOBAL TISSUE DIAGNOSTICS MARKET BY REGION, 2013-2020 ($ MILLIONS)
CHAPTER 11 GLOBAL IVD MARKET BY END USERS
INTRODUCTION
TRENDS
FIGURE 26 GLOBAL IVD MARKET SHARE BY END USER, 2014 (%)
CHAPTER 12 GLOBAL IVD MARKET PRODUCTS
INTRODUCTION
TRENDS
FIGURE 27 GLOBAL IVD MARKET SHARE BY PRODUCT TYPE, 2014 (%)
CHAPTER 13 REGIONAL ANALYSIS
INTRODUCTION
NORTH AMERICA
EUROPE
ASIA
LAAM
INTERNATIONAL HEALTH EXPENDITURE AND TRENDS
FIGURE 28 TOTAL HEALTH EXPENDITURE AS A PERCENTAGE OF GDP FOR THE TOP INDUSTRIALIZED ECONOMIES, 2010 (%)
TABLE 20 GLOBAL IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 29 GLOBAL IVD MARKET SHARE BY REGION, 2014 (%)
NORTH AMERICA
TABLE 21 NORTH AMERICA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 30 NORTH AMERICA IVD MARKET SHARE BY COUNTRY, 2014 (%)
TABLE 22 NORTH AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
U.S.
TABLE 23 U.S. IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
CANADA
TABLE 24 CANADA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
EUROPE
WESTERN EUROPE (WE)
CENTRAL AND EASTERN EUROPE (CEE)
TABLE 25 EUROPE IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 31 EUROPE IVD MARKET SHARE BY COUNTRY, 2014 (%)
FIGURE 32 WE IVD MARKET SHARE BY COUNTRY, 2014 (%)
FIGURE 33 CEE IVD MARKET SHARE BY COUNTRY, 2014 (%)
TABLE 26 EUROPE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
WESTERN EUROPE
GERMANY
TABLE 27 GERMANY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
FRANCE
TABLE 28 FRANCE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
ITALY
TABLE 29 ITALY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
SPAIN
TABLE 30 SPAIN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
U.K.
TABLE 31 U.K. IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
OTHERS
TABLE 32 OTHERS IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
CENTRAL AND EASTERN EUROPE
TURKEY
TABLE 33 TURKEY IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
RUSSIA
TABLE 34 RUSSIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
POLAND
TABLE 35 POLAND IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
GREECE
TABLE 36 GREECE IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
CZECH REPUBLIC
TABLE 37 CZECH REPUBLIC IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
OTHERS
TABLE 38 OTHERS IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
ASIA
TABLE 39 ASIA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 34 ASIA IVD MARKET SHARE BY COUNTRY, 2013-2020 (%)
TABLE 40 ASIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
JAPAN
TABLE 41 JAPAN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
CHINA
TABLE 42 CHINA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
AUSTRALIA
TABLE 43 AUSTRALIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
INDIA
TABLE 44 INDIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
SOUTH KOREA
TABLE 45 SOUTH KOREA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
TAIWAN
TABLE 46 TAIWAN IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
REST OF ASIA
TABLE 47 REST OF ASIA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
LATIN AMERICA, AFRICA AND MIDDLE EAST (LAAM)
TABLE 48 LAAM IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
TABLE 49 LAAM IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
LATIN AMERICA
TABLE 50 LATIN AMERICA IVD MARKET BY COUNTRY, THROUGH 2020 ($ MILLIONS)
FIGURE 35 LATIN AMERICA IVD MARKET SHARE BY COUNTRY, 2014 (%)
TABLE 51 LATIN AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
BRAZIL
TABLE 52 BRAZIL IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
MEXICO
TABLE 53 MEXICO IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
REST OF LATIN AMERICA
TABLE 54 REST OF LATIN AMERICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
MIDDLE EAST AND AFRICA (MEA)
TABLE 55 MIDDLE EAST AND AFRICA IVD MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
FIGURE 36 MIDDLE EAST AND AFRICA IVD MARKET SHARE BY REGION, 2014 (%)
TABLE 56 MIDDLE EAST AND AFRICA IVD MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
CHAPTER 14 EMERGING GLOBAL TECHNOLOGY TRENDS AND
DEVELOPMENTS
TRENDS
INDUSTRY DEVELOPMENTS
RAPID FINGER PRICK EBOLA TEST
ROCHE DIAGNOSTICS' ELECSYS HTLV-I/II
HIV COMBO ASSAY
BLOOD-BASED GENETIC ASSAY
PORTABLE MOLECULAR DIAGNOSTICS SYSTEM GENEXPERT OMNI
NEW INSTRUMENTS AND ASSAYS AT AACC 2015
INOVA DIAGNOSTICS' QUANTA FLASH ASSAYS
LEADCARE PLUS CLINICAL LEAD ANALYZER
DIAGNOSTIC TEST TO DIFFERENTIATE BETWEEN TYPES OF HIV INFECTIONS
IMMUNOCHEMICAL POC TESTING IN FIVE MINUTES
ASSAYS FOR DETECTING FOODBORNE PATHOGENS
TEST TO DETECT PATHOGENIC C. DIFFICILE
MOLECULAR DIAGNOSTIC TESTS FOR ONCOLOGY
RAPID DIAGNOSTIC TEST FOR MALARIA
EMERGING APPROACHES TO DIAGNOSIS OF MALARIA
TABLE 57 EMERGING APPROACHES TO MALARIA DIAGNOSIS
MALARIA IVD TECHNOLOGIES IN DEVELOPMENT
TABLE 58 MALARIA DIAGNOSTIC TECHNOLOGIES UNDER DEVELOPMENT
TABLE 59 IVD PRODUCT APPROVALS, 2014-2015
ACADEMIC RESEARCH AND DEVELOPMENT
RAPID TECHNIQUE TO DETECT DISEASE-CAUSING DNA
SALIVA TEST TO PREDICT ALZHEIMER'S DISEASE
MOBILE DNA TEST FOR CHLAMYDIA
BLOOD TEST FOR VIRAL INFECTIONS
RAPID IVD FOR DENGUE
CHAPTER 15 TECHNOLOGY DEVELOPMENT OPPORTUNITIES IN IVD
INDUSTRY
OPPORTUNITY AREAS
IVD FOR NEGLECTED INFECTIOUS DISEASES
PORTABLE DEVICES COMPATIBLE WITH SIMPLE DETECTION PLATFORMS
CHEMISTRY-BASED PORTABLE ANALYZERS
IMPROVED SAMPLE PRESERVATION TECHNOLOGIES
NEW DETECTION TECHNOLOGIES
ALTERNATIVE TECHNOLOGIES TO PCR
KEY BIOMARKERS FOR DISEASES OF THE DEVELOPING WORLD
FIGURE 37 BIOMARKER RELATED PUBLICATIONS, 2009-2014 (NO. OF PUBLICATIONS)
FIGURE 38 BIOMARKER-BASED TESTS CLEARED BY 510(K), 2009-2014 (NO. OF BIOMARKER-BASED TESTS)
TABLE 60 BIOMARKER-BASED TESTS RELEASED PER COMPANY, 2013 (NO. OF TESTS)
FIGURE 39 BIOMARKERS IN FDA-CLEARED TESTS, 2010-2014 (NO. OF TESTS CLEARED)
MICROFLUIDIC PLATFORM BASED POC TESTS FOR REMOTE SETTINGS
COMBINING MULTIPLE DETECTION TECHNOLOGIES INTO A SINGLE
INSTRUMENT
CHAPTER 16 FUNDING ANALYSIS AND INDUSTRY ACTIVITY
PUBLIC FUNDING
EUROPE
U.S.
FIGURE 40 NCI'S FUNDING SHARE FOR IVDS AND VARIOUS OTHER DISCIPLINES, 2014 (%)
SWISS-BASED SERI FUNDS EBOLA DIAGNOSTICS WORK BY FIND
EUROPEAN UNION AWARD FOR FABPULOUS BV FOR CARDIAC IVD
PRIVATE FUNDING
CANADIAN START-UP XAGENIC RECEIVES SERIES B VC FUNDING
BLOOD-BASED IVD FOR CANCER
OPTICS-BASED IVD
IVD FOR LIVER DISEASES
DNA-BASED IVD FOR PRENATAL AND CANCER TESTING
IVD FOR ORAL CANCER
IVD FOR BLADDER CANCER
TESTS FOR INFECTIOUS DISEASES AND CANCERS
TAIWAN-BASED MOLECULAR DIAGNOSTICS FIRM RECEIVES PRIVATE
FUNDING
MERGERS AND ACQUISITIONS
FIGURE 41 IVD MERGERS AND ACQUISITIONS, 2012-2015 (NO. OF DEALS)
FIGURE 42 SHARE OF MERGERS AND ACQUISITIONS BY CATEGORY, 2012-2015 (%)
TABLE 61 MERGERS AND ACQUISITIONS, 2012-JUNE 2015
CHAPTER 17 PATENT LANDSCAPE
FIGURE 43 PATENTS BY PUBLICATION DATE, 2012-JUNE 2015 (NUMBERS)
FIGURE 44 PATENTS BY SUBSEGMENT AND PUBLICATION DATE, 2012–JUNE 2015 (NUMBERS)
IMMUNOASSAYS
FIGURE 45 IMMUNOASSAYS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
CLINICAL CHEMISTRY
FIGURE 46 CLINICAL CHEMISTRY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
POC TESTING
FIGURE 47 POCT PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
MOLECULAR DIAGNOSTICS
FIGURE 48 MOLECULAR DIAGNOSTICS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
MICROBIOLOGY
FIGURE 49 MICROBIOLOGY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015* (NUMBERS)
HEMATOLOGY
FIGURE 50 HEMATOLOGY PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
TISSUE DIAGNOSTICS
FIGURE 51 TISSUE DIAGNOSTICS PATENT DISTRIBUTION BY SECTOR, 2011-JUNE 2015 (NUMBERS)
CHAPTER 18 COMPANY PROFILES
ABBOTT DIAGNOSTICS INC.
GEOGRAPHIC REACH
GLOBAL REACH
SALES AND MARKETING
STRATEGY
ALERE SAN DIEGO INC.
GEOGRAPHIC REACH
SALES AND MARKETING
STRATEGY
BAYER DIABETES CARE (NOW PART OF PANASONIC HEALTHCARE)
BECKMAN COULTER (PART OF DANAHER)
GEOGRAPHIC REACH
OPERATIONS
SALES AND MARKETING
STRATEGY
BECTON DICKINSON
STRATEGY
BIOMERIEUX
GLOBAL REACH
SALES AND MARKETING
STRATEGY
BIORAD
SALES AND MARKETING
ELITECH GROUP
HOLOGIC INC.
SALES AND MARKETING
KEM-EN-TEC DIAGNOSTICS A/S
ORTHO CLINICAL DIAGNOSTICS
ROCHE DIAGNOSTICS CORP.
GEOGRAPHIC REACH
SALES AND MARKETING
FINANCIAL PERFORMANCE
STRATEGY
SIEMENS HEALTHCARE DIAGNOSTICS INC.
GEOGRAPHIC REACH
SALES AND MARKETING
STRATEGY
SYSMEX
THERMO FISHER SCIENTIFIC INC.
STRATEGY
TRANSASIA BIO-MEDICALS
WERFEN GROUP
CHAPTER 19 APPENDIX
LIST OF IVD MARKET PARTICIPANTS
LIST OF ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report